Akebia Therapeutics, Inc.
Expected move
InputsNext report
Last report
Largest filed tie
13F top-10 QoQ
Top fund weight
Last report1 of 8 at or beyond impliedshaded = implied▲▼ = realized× = |realized| ÷ implied
−26.02%
vs ±35.9% implied · ×0.73
shaded = implied · ▲▼ = realized
Fund move
Fund move
Akebia Therapeutics, Inc.
0.71
No thesis.
| Rank | Manager | Value | % 13F | ||
|---|---|---|---|---|---|
| 1 | BlackRockBlackRockindex-like | $22.8M | 18.37% | +6.92% | |
| 2 | Vanguard Capital ManagementVanguardindex-like | $12.9M | 10.41% | +1.39% | |
| 3 | AQR Capital ManagementAQR | $10.4M | 8.41% | +410.51% | |
| 4 | Geode Capital ManagementGeodeindex-like | $7.7M | 6.19% | +4.26% | |
| 5 | State StreetState Streetindex-like | $6.1M | 4.96% | −53.58% | |
| 6 | Jacobs Levy Equity ManagementJacobs Levy Equity | $4.9M | 3.93% | +894.49% | |
| 7 | Acadian Asset ManagementAcadian | $4.6M | 3.68% | +190.83% | |
| 8 | Goldman Sachs GroupGoldman Sachs | $4.2M | 3.39% | +2.40% | |
| 9 | Millennium ManagementMillennium | $3.6M | 2.94% | +34.05% | |
| 10 | Vanguard Portfolio ManagementVanguard Portfolioindex-like | $2.9M | 2.33% | +14.38% | |
| 11 | Two Sigma InvestmentsTwo Sigma | $2.8M | 2.24% | +87.75% | |
| 12 | Charles Schwab Investment ManagementCharles Schwabindex-like | $2.6M | 2.11% | +14.13% | |
| 13 | Northern TrustNorthern Trustindex-like | $2.5M | 1.99% | +11.04% | |
| 14 | Nantahala Capital ManagementNantahala | $2.3M | 1.84% | 0.00% | |
| 15 | Citadel AdvisorsCitadel | $2.3M | 1.82% | +14.80% | |
| 16 | Vanguard Fiduciary TrustVanguard Fiduciary Trustindex-like | $2.2M | 1.75% | +7.28% | |
| 17 | FMRFMR | $2.1M | 1.72% | +40.12% | |
| 18 | Qube Research & TechnologiesQube Research & Technologies | $2.0M | 1.64% | −25.70% | |
| 19 | UBS GroupUBS | $1.6M | 1.26% | +77.31% | |
| 20 | Renaissance TechnologiesRenaissance Technologies | $1.4M | 1.13% | −33.23% | |
| 21 | CitigroupCitigroup | $1.3M | 1.03% | −60.60% | |
| 22 | Susquehanna International GroupSusquehanna International | $1.3M | 1.01% | −0.29% | |
| 23 | Hennion & Walsh Asset ManagementHennion & Walsh | $957,291 | 0.77% | +32.61% | |
| 24 | Morgan StanleyMorgan Stanley | $799,756 | 0.64% | +20.68% | |
| 25 | InvescoInvesco | $792,218 | 0.64% | −3.50% |
170 managers report $124.0M of Akebia Therapeutics on form 13F for the quarter ended Jun 30 '26. 19 of them hold 80% of it; BlackRock is largest at 18.37%.
Linked news
Expected move
No implied move.
No implied move.
No implied move.